| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = -$6,251 ) |
| | 2025 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R35GM139336 | Discovery and development of artificial nucleic acid ligands to probe cellular interactions | 000 | 5 | NIH | 11/4/2024 | $0 |
| | 2025 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R34MH121295 | Optimizing Study Design to Test a Community-level Intervention to Reduce Intersectional Stigma and Increase HIV Testing and Prevention among African-American/Black MSM | 001 | 3 | NIH | 10/9/2024 | -$1 |
| | 2025 | 2022 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R21DC019737 | Development of hemispheric specializations during Auditory Cortex critical periods | 001 | 2 | NIH | 10/8/2024 | -$2,611 |
| | 2025 | 2022 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R21DC019737 | Development of hemispheric specializations during Auditory Cortex critical periods | 000 | 2 | NIH | 10/8/2024 | -$3,638 |
| | 2025 | 2021 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R34MH121295 | Optimizing Study Design to Test a Community-level Intervention to Reduce Intersectional Stigma and Increase HIV Testing and Prevention among African-American/Black MSM | 000 | 3 | NIH | 10/9/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $11,507,291 ) (Continued on the next page) |
| | 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R25DA035161 | Translational Research Training on Addictions for Racial/Ethnic Minorities | 000 | 10 | NIH | 4/23/2024 | $315,742 |
| | 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | T34GM149459 | U-RISE at City College of New York | 000 | 2 | NIH | 3/14/2024 | $268,986 |
| | 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | T34GM137870 | Bridges to the Baccalaureate Research Training Program (T34) for racial/ethnic minorities at the Borough of Manhattan Community College (BMCC) and the City College of New York (CCNY) | 000 | 4 | NIH | 8/16/2024 | $350,862 |
| | 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | U54MD017979 | NYCenter for Minority Health, Equity and Social Justice | 000 | 1 | NIH | 8/23/2024 | $3,939,001 |
| | 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R01HL168191 | Hyperglycemia-induced regulatory mechanism of ER stress by arresting domain-containing protein 4 in diabetic cardiomyopathy | 000 | 1 | NIH | 1/9/2024 | $392,500 |
| | 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R16GM145474 | Microcalcifications in Atherosclerotic Plaque | 000 | 3 | NIH | 8/13/2024 | $157,000 |
| | 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R01NS130484 | Interaction of Motor Learning with Transcranial Direct Current - Efficacy and Mechanisms | 001 | 2 | NIH | 4/11/2024 | $40,222 |
| | 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R01NS130484 | Interaction of Motor Learning with Transcranial Direct Current - Efficacy and Mechanisms | 000 | 2 | NIH | 11/21/2023 | $517,159 |
| | 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | U54CA132378 | 1/2 CCNY-MSK Partnership for Cancer Research, Education and Community Outreach | 004 | 16 | NIH | 9/18/2024 | $1,334,500 |
| | 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R01HL166620 | Arrestin domain-containing protein 4 as a novel regulator of glucose metabolism in the ischemic heart | 000 | 2 | NIH | 7/5/2024 | $384,650 |
| | 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R35GM139336 | Discovery and development of artificial nucleic acid ligands to probe cellular interactions | 004 | 5 | NIH | 5/20/2024 | $39,126 |
| | 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R01NS112996 | kHz frequency Spinal Cord Stimulation: Novel Temperature-Based Mechanisms of Action | 001 | 3 | NIH | 4/26/2024 | $317,925 |
| | 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | T32GM136499 | G-RISE at The City College of New York | 001 | 5 | NIH | 7/1/2024 | $24,996 |
| | 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | T32GM136499 | G-RISE at The City College of New York | 002 | 5 | NIH | 9/13/2024 | $102,694 |
| | 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R35GM139336 | Discovery and development of artificial nucleic acid ligands to probe cellular interactions | 000 | 5 | NIH | 11/27/2023 | $352,142 |
| | 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | T32GM136499 | G-RISE at The City College of New York | 000 | 5 | NIH | 4/12/2024 | $600,075 |
| | 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R16GM145496 | Explaining the variability in focused ultrasound neuromodulation | 000 | 3 | NIH | 6/5/2024 | $158,150 |
| | 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R16NS129675 | Nonpeptide Neurotrophic Mechanisms in Spinal Cord Repair | 000 | 3 | NIH | 4/25/2024 | $157,000 |
| | 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R01GM131079 | Stereospecific Cross-Coupling Reactions as a Tool for Three Dimensional Molecular Diversification | 000 | 6 | NIH | 5/8/2024 | $326,560 |
| | 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R03AR084261 | Osteogenesis imperfecta caused by TMEM38B mutation: a deep investigation of cellular and extracellular consequences to identify new therapeutic targets | 001 | 1 | NIH | 9/26/2024 | $0 |
| | 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R03AR084261 | Osteogenesis imperfecta caused by TMEM38B mutation: a deep investigation of cellular and extracellular consequences to identify new therapeutic targets | 000 | 1 | NIH | 9/25/2024 | $159,594 |
| | 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R25CA112383 | Cancer Epidemiology Education in Special Populations (CEESP) | 000 | 19 | NIH | 9/5/2024 | $409,531 |
| | 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R16GM145403 | Molecular Drivers of FABP-mediated Endocannabinoid Signaling for Appetite Regulation | 004 | 3 | NIH | 8/28/2024 | $99,999 |
| | 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R16GM145403 | Molecular Drivers of FABP-mediated Endocannabinoid Signaling for Appetite Regulation | 005 | 3 | NIH | 8/29/2024 | $25,374 |
| | 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R16GM145601 | Development of a photothermal stimulator array for controlled neuron stimulation | 000 | 3 | NIH | 8/14/2024 | $157,452 |
| | 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | SC1GM139701 | Mechanism of membrane fusion involving the Gram-negative bacteria outer membrane | 001 | 4 | NIH | 7/19/2024 | $37,825 |
| | 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R16GM145403 | Molecular Drivers of FABP-mediated Endocannabinoid Signaling for Appetite Regulation | 003 | 3 | NIH | 8/1/2024 | $92,881 |
| | 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R16GM145403 | Molecular Drivers of FABP-mediated Endocannabinoid Signaling for Appetite Regulation | 002 | 2 | NIH | 7/31/2024 | $2,308 |
| | 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R16GM145403 | Molecular Drivers of FABP-mediated Endocannabinoid Signaling for Appetite Regulation | 001 | 3 | NIH | 7/23/2024 | $157,000 |
| | 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R16GM145403 | Molecular Drivers of FABP-mediated Endocannabinoid Signaling for Appetite Regulation | 000 | 2 | NIH | 6/18/2024 | $15,480 |
| | 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R35GM142833 | Integrating Real-Time Multi-System Cytokine Signaling in Chronic Disease | 001 | 4 | NIH | 5/21/2024 | $21,062 |
| | 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R35GM142833 | Integrating Real-Time Multi-System Cytokine Signaling in Chronic Disease | 000 | 4 | NIH | 5/20/2024 | $392,500 |
| | 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R01CA247910 | Machine learning for risk-adjusted breast MRI screening | 001 | 4 | NIH | 4/17/2024 | $33,147 |
| | 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | SC1GM139701 | Mechanism of membrane fusion involving the Gram-negative bacteria outer membrane | 000 | 4 | NIH | 4/8/2024 | $340,425 |
| | 2024 | 2024 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R01CA247910 | Machine learning for risk-adjusted breast MRI screening | 000 | 4 | NIH | 11/10/2023 | $596,618 |
| | 2024 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R01MH129198 | Estimating the Impact of a Multilevel, Multicomponent Intervention to Increase Uptake of HIV Testing and Biomedical HIV Prevention among African-American/Black Gay, Bisexual and Same-gender Loving Men | 000 | 2 | NIH | 6/25/2024 | $0 |
| | 2024 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | U54CA132378 | 1/2 CCNY-MSK Partnership for Cancer Research, Education and Community Outreach | 000 | 15 | NIH | 4/5/2024 | $0 |
| | 2024 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | U54CA132378 | 1/2 CCNY-MSK Partnership for Cancer Research, Education and Community Outreach | 003 | 15 | NIH | 9/12/2024 | $0 |
| | 2024 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | U54CA132378 | 1/2 CCNY-MSK Partnership for Cancer Research, Education and Community Outreach | 002 | 15 | NIH | 9/12/2024 | $0 |
| | 2024 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | U54CA132378 | 1/2 CCNY-MSK Partnership for Cancer Research, Education and Community Outreach | 001 | 15 | NIH | 9/12/2024 | $0 |
| | 2024 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R34MH121295 | Optimizing Study Design to Test a Community-level Intervention to Reduce Intersectional Stigma and Increase HIV Testing and Prevention among African-American/Black MSM | 002 | 3 | NIH | 12/15/2023 | -$87,680 |
| | 2024 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R01NS112996 | kHz frequency Spinal Cord Stimulation: Novel Temperature-Based Mechanisms of Action | 000 | 2 | NIH | 4/17/2024 | $0 |
| | 2024 | 2023 | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 160 CONVENT AVE | NEW YORK | NY | 10031-9101 | NEW YORK | USA | R61DA059032 | Onsite PTSD Treatment to Improve MOUD Outcomes (OPTIMO): a hybrid Type 1 effectiveness-implementation trial of harm reduction PTSD care at syringe service programs | 000 | 1 | NIH | 3/1/2024 | $0 |
|
